Advertisement
Advertisement
Chinese coronavirus vaccines
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
A teacher receives a dose of the CanSino Biologics Covid-19 vaccine at an inoculation centre in Guadalajara, Mexico, on April 28. Photo: AFP

Coronavirus: China’s CanSino says vaccine booster shot can reverse drop in antibodies

  • A second dose six months after the single-shot vaccine can make antibody levels spike about eight-fold in two weeks, CanSino’s chief scientific officer said
Antibody levels in people inoculated with CanSino Biologics’ single-dose Covid-19 vaccine fell by some 30 per cent after six months, but a booster shot could offer a significant lift, a senior executive said late on Thursday.

The decline in antibodies does not necessarily mean the shots will lose their protection, though how fast they wane could still serve as an important indicator of the immune response, Zhu Tao, chief scientific officer at CanSino, said in an online presentation.

Apart from durable antibodies, researchers have said that other components in a person’s immune system elicited by Covid vaccines, such as T cell and B cell memory, may also contribute to protection.

Six months after being inoculated with a CanSino vaccine, neutralising antibodies were at roughly 70 per cent of the level seen 28 days after the shot, Zhu said, citing data from 35 vaccinated people.

When a second dose was given after six months, antibody levels shot up about eight-fold two weeks after the shot, Zhu said, citing data from 28 people.

What next for Chinese vaccines after first WHO approvals?

Five out of the seven vaccines approved in China are two-shot inactivated vaccines such as those from Sinovac and state-backed Sinopharm that contain “killed” coronavirus. CanSino’s shot uses a modified common cold virus known as adenovirus to ferry genetic information from the spike protein of the coronavirus into the human body.

A third booster shot of CanSino’s vaccine three to six months after the second shot of an inactivated vaccine generated significantly higher antibody levels, versus using an inactivated vaccine as a third-dose booster, Zhu said, citing data from about 200 participants in a clinical trial.

Post